Kymriah 1.2 × 106 – 6 × 108 cells dispersion for infusion

Licence status
Authorised: 23/08/2018
Active substances
AUTOGLAS T CELLS TRANSDUCED WITH LENTIVIRAL VECTOR CONTAINING A CHIMERIC ANTIGEN RECEPTOR DIRECTED AGAINST CD1
Dosage Form
Dispersion for infusion
Licence number
EU/1/18/1297/001
Licence holder
Novartis Europharm Limited

Product documents

Licence information

ATC code
L01 ANTINEOPLASTIC AGENTS
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
23/08/2018